Kidney transplant drug showdown: which is safer Long-Term?
NCT ID NCT00811915
First seen Apr 15, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study looked at kidney transplant patients to compare two drugs—sirolimus and tacrolimus—both given with another drug called mycophenolate mofetil. The goal was to see which combination caused fewer long-term problems like kidney damage, diabetes, or cancer. The study was stopped early, but it aimed to help doctors choose the best treatment for keeping transplanted kidneys healthy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UHAmiens
Amiens, France
-
UHAngers
Angers, 49933, France
-
UHCaen
Caen, 14000, France
-
UHLimoges
Limoges, France
-
UHNecker
Paris, 75015, France
-
UHRennes
Rennes, 35000, France
-
UHRouen
Rouen, 76000, France
-
UHTours
Tours, France
Conditions
Explore the condition pages connected to this study.